GlassScriptPhysician profile
Grady R Fort
NPI 1982765582
$490.45
in general payments reported to CMS, 2019-2025
9 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.14 · 2020: $22.57 · 2021: $17.84 · 2022: $40.51 · 2023: $84.07 · 2024: $136 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $143.04 | 2024-2025 | Breztri, Airsupra |
| Amgen INC. | $110.22 | 2020-2025 | Evenity, Prolia |
| Pfizer INC. | $59.84 | 2023-2024 | |
| Exact Sciences Corporation | $45.43 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $43.67 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.51 | 2022 | |
| Merck Sharp & Dohme LLC | $17.84 | 2021 | |
| Insulet Corporation | $15.14 | 2019 | |
| Lilly USA, LLC | $14.76 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grady Fort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.